As a side note, the PPMI is a landmark observational clinical study to comprehensively evaluate cohorts of significant interest using advanced imaging, biologic sampling and clinical and behavioral assessments to identify biomarkers of Parkinson’s disease progression.

PPMI is taking place at clinical sites in the United States, Europe, and Australia. Data and samples acquired from study participants will enable the development of a comprehensive Parkinson’s database and biorepository, which is currently available to the scientific community to conduct field-changing research. The data base is OPEN to all researchers. There have been over 78,000 downloads of the data to date.

We owe a thanks to the The Michael J. Fox Foundation for sponsoring and supporting this study.